发明申请
US20110071042A1 BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
有权
用于确定乳腺癌细胞对HER2靶向治疗敏感性的生物标志物
- 专利标题： BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
- 专利标题（中）： 用于确定乳腺癌细胞对HER2靶向治疗敏感性的生物标志物
-
申请号： US12854144申请日： 2010-08-10
-
公开(公告)号： US20110071042A1公开(公告)日： 2011-03-24
- 发明人: Phillip Kim , Xinjun Liu , Richard Kirkland , Tani Lee , Belen Ybarrondo , Sharat Singh
- 申请人： Phillip Kim , Xinjun Liu , Richard Kirkland , Tani Lee , Belen Ybarrondo , Sharat Singh
- 申请人地址： US CA San Diego
- 专利权人： Prometheus Laboratories Inc.
- 当前专利权人： Prometheus Laboratories Inc.
- 当前专利权人地址： US CA San Diego
- 主分类号： C40B30/04
- IPC分类号： C40B30/04 ; G01N33/566
摘要：
The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
公开/授权文献
信息查询
